Tubulin-folding cofactor A (TFC A) is a molecular post-chaperonin that is involved in the -tubulin-folding pathway. It has been identified in many organisms including yeasts, humans and plants. In this work, Arabidopsis thaliana TFC A was expressed in Escherichia coli and purified to homogeneity. After thrombin cleavage, a well diffracting crystal was obtained by the sittingdrop vapour-diffusion method at 289 K. The crystal diffracted to 1.6 Å resolution using synchrotron radiation and belonged to space group I4 1 , with unit-cell parameters a = 55.0, b = 55.0, c = 67.4 Å .
Introduction
Microtubules, which are components of the cytoskeleton, are important in morphogenesis, cell division, intracellular transport and the establishment of cell polarity (Joshi, 1998; Mathur & Chua, 2000) . The biogenesis of these microtubules plays an important role in the regulation of these functions. The microtubule polymers are made up of -tubulin heterodimers. The formation of polymerizationcompetent -tubulin heterodimers is a complex process that requires several molecular chaperones and tubulin-folding cofactors (TFCs; Lopez- Fanarraga et al., 2001) . The prefoldin (Vainberg et al., 1998) first associates with the nascent -and -tubulin and transfers them to CCT (cytosolic containing TCP-1; Lewis et al., 1996) . TFC A then binds to -tubulin and TFC B binds to -tubulin. Subsequently, TFC D replaces TFC A to interact with -tubulin, while TFC E replaces TFC B to interact with -tubulin. Once the TFC D--tubulin-TFC E--tubulin complex has been formed, the tubulin heterodimers can be released in the presence of TFC C and GTP.
TFC A has been identified in many organisms, including yeasts, mammals and plants (Archer et al., 1995; Kirik et al., 2002; Campo et al., 1994) . Mammalian TFC A (CoA) was first identified as a molecular chaperone for -tubulin (Gao et al., 1994) . In vitro experiments have shown that CoA binds noncovalently to -tubulin and serves as a reservoir for excess -tubulin (Llosa et al., 1996; Fanarraga et al., 1999) . The budding yeast orthologue Rbl2p has been identified as a protein that is capable of rescuing cells from lethal -tubulin overexpression (Archer et al., 1995) . The Arabidopsis thaliana TFC A orthologue encoded by KIESEL (KIS) was identified from morphogenesis-based mutation screens. kis (A) mutant plants exhibit cell-morphogenesis defects and abnormal cell-division phenotypes. KIS is also involved in maintaining the balance between -tubulin and -tubulin monomers (Steinborn et al., 2002) .
The structures of Rbl2p and human CoA have been reported (Steinbacher, 1999; Guasch et al., 2002) . Rbl2p forms a homodimer and is predicted to interact with -tubulin via the loop regions of the homodimer (You et al., 2004) . However, human CoA crystallizes as a monomer and binds to -tubulin via the helical region (Guasch et al., 2002) . The structure of TFC A in plants has not been reported and it is not clear how it interacts with -tubulin. Here, we describe the preparation, crystallization and preliminary X-ray analysis of A. thaliana TFC A. The structure of this protein will further our understanding of the function of the TFC A gene in plants.
Materials and methods

Gene cloning and expression
The KIS gene (AT2G30410) was amplified by stepdown PCR using A. thaliana cDNA as the template. The forward (5 0 -GGTACTGCA-TATGGCAACGATAAGGAACT-3 0 ) and reverse (5 0 -GTCGTCG-ACTCAGGCATCTTCAGTGGG-3 0 ) primers used for PCR were designed to introduce an NdeI site at the N-terminus and a SalI site at the C-terminus. The PCR product was digested and ligated into the NdeI and SalI sites of pET-28a(+) (Novagen) vector with an N-terminal His 6 -fusion tag. The construct was verified by DNA sequencing. The recombinant plasmid was transformed into Escherichia coli Rosetta (DE3) cells for protein expression.
Transformed cells were cultured at 310 K in LB medium containing 50 mg ml À1 kanamycin and 34 mg ml À1 chloramphenicol. When the cells reached an OD 600 of 0.6, protein expression was induced by the addition of isopropyl -d-1-thiogalactopyranoside (IPTG) to a final concentration of 1 mM and culturing for another 4 h.
Protein purification
The cells were harvested by centrifugation at 4000g for 15 min at 277 K and resuspended in buffer A (20 mM Tris-HCl pH 7.5, 500 mM NaCl). After sonication, the cellular debris was removed by centrifugation at 18 000g for 30 min at 277 K. The supernatant was loaded onto a 5 ml Ni 2+ -affinity column (HiTrap Chelating HP, GE Healthcare) pre-equilibrated with buffer A. The column was washed with 40 ml buffer A containing 50 mM imidazole before the target protein was eluted with a linear gradient of 50-500 mM imidazole. The eluted His-tagged protein was pooled and loaded onto a 120 ml HiLoad Superdex 75 gel-filtration column (GE Healthcare, USA) equilibrated with buffer B (20 mM Tris-HCl pH 7.5, 150 mM NaCl) for further purification. The fractions were concentrated to 15 mg ml À1 using an Amicon Ultra 5K concentrator (Millipore, USA). Subsequently, the first 17 amino acids of the N-terminus of the His-tagged recombinant TFC A protein were cleaved with thrombin by incubating 5 mg protein with 10 units of protease for 4 h at room temperature. Gel-filtration chromatography in buffer B was again applied to the recombinant TFC A protein without His tag and the fractions were concentrated to 10 mg ml À1 for crystallization trials
Crystallization
The recombinant TFC A protein without His tag was crystallized at 289 K using the sitting-drop vapour-diffusion method with a 48-2 crystallization plate (XtalQuest Inc., Beijing, People's Republic of China). Hampton Research Crystal Screen, Crystal Screen 2 and Index kits (Hampton Research, USA) were used for initial crystallization screening. 1 ml protein solution was mixed with 1 ml reservoir solution and equilibrated against 100 ml reservoir solution.
X-ray diffraction data collection
X-ray diffraction data were collected using a MAR CCD system on beamline BW7A of the European Molecular Biology Laboratory (EMBL) at the DORIS storage ring, DESY, Hamburg. The crystal was flash-frozen to 100 K in a nitrogen-gas stream during data collection and the diffraction data were processed to 1.6 Å with the HKL-2000 package (Otwinowski & Minor, 1997) .
Results and discussion
The A. thaliana TFC A protein was expressed in E. coli in a soluble form and was purified by a series of chromatographic steps. The purity of the protein was estimated to be about 95% by SDS-PAGE (data not shown).
We initially used the recombinant His-tagged TFC A protein to perform crystal screening and clustered needle-shaped crystals were observed after two weeks in Crystal Screen condition No. 24 [30%(w/v) polyethylene glycol (PEG) 4000, 0.1 M Tris-HCl pH 8.5, 0.2 M sodium acetate]. Starting from this result, about 300 crystallization conditions were tested, varying the pH, precipitant and salt concentration, for optimization. However, this did not improve the diffraction of the crystals. It was found that the protein formed crystals with better diffraction quality after storing the protein sample at 277 K for three weeks. The crystals were then checked by SDS-PAGE, which showed that the protein was still pure but that its molecular mass was smaller than that of the fresh protein that purified from the Superdex 75 column (Fig. 1a) . Western blotting analysis with anti-His monoclonal antibody indicated that the N-terminal His tag had been degraded (Fig. 1b) . Therefore, the His-tagged TFC A protein was digested with thrombin and the N-terminally cleaved sample was used for further crystallization. Well diffracting crystals were obtained using the condition 35%(w/v) PEG 3350, 0.1 M sodium acetate pH 4.6 and 0.4 M sodium nitrate after three weeks using the recombinant TFC A protein without His tag (Fig. 2) .
The crystal diffracted to 1.6 Å resolution (Fig. 3 ) and belonged to space group I4 1 , with unit-cell parameters a = b = 55.0, c = 67.4 Å , = = = 90 . The crystal contains one molecule per asymmetric unit, giving a V M value of 1.94 Å 3 Da À1 and corresponding to a solvent content of 36.6% (Matthews, 1968) . The data-collection statistics are listed in Table 1 .
The first structure from the cofactor A family to be reported was that of yeast Rbl2p (PDB code 1qsd; Steinbacher, 1999) . Rbl2p crystallizes as a homodimer and each monomer forms a three-helix bundle. The sequence identity between Rbl2p and human CoA is 32%, but subsequent structure determination of human CoA failed when using Rbl2p as a search model for molecular replacement (Guasch et al., 2002) . The final structure of human CoA (PDB code 1h7c; Guasch et al., 2002) solved by the multiwavelength anomalous diffraction method demonstrates that there are structural differences between these two proteins. The C-terminus of helix 1 and the middle part of helix 2 of the two proteins do not match. Meanwhile, two loops of Rbl2p and human CoA adopt different conformations. Moreover, the oligomeric state is also different: human CoA crystallizes as a monomer.
A. thaliana TFC A shares about 45% identity (65% similarity) to human CoA and 31% identity (56% similarity) to Rbl2p. Therefore, we attempted to solve the structure of A. thaliana TFC A using the molecular-replacement method. Structure determination was successful when the structure of Rbl2p was used as the search model. The coordinates and structure factors have been deposited in the Protein Data Bank (entry 3mxz). 
